Methods for producing modified glycoproteins
AssigneeGlycoFi, Inc.
InventorTillman U. Gerngross
Life of this patent
Estimating the term…
Loading patent…
AssigneeGlycoFi, Inc.
InventorTillman U. Gerngross
Estimating the term…
Cell lines having genetically modified glycosylation pathways that allow them to carry out a sequence of enzymatic reactions, which mimic the processing of glycoproteins in humans, have been developed. Recombinant proteins expressed in these engineered hosts yield glycoproteins more similar, if not substantially identical, to their human counterparts. The lower eukaryotes, which ordinarily produce high-mannose containing N-glycans, including unicellular and multicellular fungi are modified to produce N-glycans such as Man5GlcNAc2 or other structures along human glycosylation pathways. This is achieved using a combination of engineering and/or selection of strains which: do not express certain enzymes which create the undesirable complex structures characteristic of the fungal glycoproteins, which express exogenous enzymes selected either to have optimal activity under the conditions present in the fungi where activity is desired, or which are targeted to an organelle where optimal activity is achieved, and combinations thereof wherein the genetically engineered eukaryote expresses multiple exogenous enzymes required to produce “human-like” glycoproteins.
A yeast or filamentous fungal host cell that does not have an alpha-1,6 mannosyltransferase activity with respect to an N-glycan on a glycoprotein, comprising a nucleic acid encoding an alpha-1,2 mannosidase enzyme selected to have optimal activity in the endoplasmic reticulum (ER) or Golgi of said host cell, the enzyme comprising:
A yeast or filamentous fungal host cell that does not have alpha-1,6 mannosyltransferase activity with respect to the N-glycan on a glycoprotein, the host cell comprising one or more nucleic acids encoding at least two enzymes, the first enzyme selected to have optimal activity in the endoplasmatic reticulum (ER) or Golgi of said host cell, the first enzyme comprising:
A yeast host cell that does not have an alpha-1,6 mannosyltransferase activity with respect to an N-glycan on a glycoprotein, comprising a nucleic acid encoding an alpha-1,2 mannosidase enzyme selected to have optimal activity in the endoplasmic reticulum (ER) or Golgi of said host cell, the enzyme comprising:
A yeast host cell that does not have alpha-1,6 mannosyltransferase activity with respect to the N-glycan on a glycoprotein, the host cell comprising one or more nucleic acids encoding at least two enzymes, the first enzyme selected to have optimal activity in the endoplasmatic reticulum (ER) or Golgi of said host cell, the first enzyme comprising:
Dependencies are inferred from the claim text.